Skip to main content
. 2021 Sep 23;65:10.29219/fnr.v65.7721. doi: 10.29219/fnr.v65.7721

Fig. 1.

Fig. 1

Study design of the T2D-GENE trial. Participants in the intervention and control groups of the trial are divided into two groups based on the genetic risk score for type 2 diabetes (low genetic risk and high genetic risk). IFG, impaired fasting glucose; IGT, impaired glucose tolerance. The duration of the intervention is follow-up time is 3 years for all participants.